Ziprasidone
Pricing Report NDC 59762-2004-1

Latest NADAC: $0.30767 per EA · Effective Jul 17, 2024 · Est. package price $18.46 (60 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Ziprasidone (NDC 59762-2004-1) is $0.30767 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 17, 2024.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 60 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.30767
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 17, 2024
Billable Units
60 EA
Estimated Package Price
$18.46
Data Status
As of Aug 14, 2024
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
59762-2004-1
Description
60 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.28597 to $2.03793 per EA. Over this 10 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2860 - $2.0379
Market Volatility
612.64% Variance
Latest Trend
1.36%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 17, 2024 $0.30767 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $0.30354 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $0.28597 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $0.33090 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2024 $0.39401 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2024 $0.39847 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2024 $0.34882 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 20, 2023 $0.32049 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 22, 2023 $0.41792 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2023 $0.32843 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2023 $0.31969 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $0.32243 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026